Viewing Study NCT04229459


Ignite Creation Date: 2025-12-24 @ 2:34 PM
Ignite Modification Date: 2026-01-17 @ 11:10 PM
Study NCT ID: NCT04229459
Status: RECRUITING
Last Update Posted: 2020-01-18
First Post: 2020-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
Sponsor: Baruch Brenner
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Esophageal Cancer View
None Esophageal Squamous Cell Carcinoma View
None Cetuximab View
None Nivolumab View